Chest Deformities, Funnel Chest, Pectus Excavatum, Pectus Excavatum Deformity
Conditions
Keywords
Funnel chest, Pectus excavatum, Exercise, Exercise therapy, Vacuum, Tissue expansion devices
Brief summary
Research on exercise methods for pectus excavatum (PE) is limited, highlighting the need for further studies. This study investigated the effects of Schroth-based exercise therapy combined with vacuum treatment in 35 adolescents with PE, divided into a vacuum + exercise group (n=19) and a vacuum-only group (n=16). Outcomes included deformity severity, sagittal posture, thoracic cage and spinal mobility, muscle endurance, and quality of life. The combination therapy significantly improved sagittal spinal posture (craniovertebral, thoracic, thoracolumbar, lumbar angles) and deformity-specific quality of life (Nuss Questionnaire scores) compared to vacuum-only treatment.
Interventions
OTHERExercise
Due to the limited research on exercise approaches for pectus excavatum, further investigation in this field is needed. This study aims to explore the impact of Schroth-based exercise therapy on adolescents with pectus excavatum.
Sponsors
Hacettepe University
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* having pectus excavatum * being 10-18 years * having Haller index more than 2.5
Exclusion criteria
* Individuals with pectus excavatum associated with a syndrome Individuals with mixed deformity * Individuals who have previously received any conservative treatment or surgery for chest deformity or spinal issues * Individuals with neuromuscular, rheumatic, or chronic systemic diseases
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Primary Outcome Measure 1: Deformity Severity | 12 weeks | Primary Outcome Measure 1: Deformity Severity Measurement: Anthropometric Index (cm) Details: Repeated, in cm. Time frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment |
| Primary Outcome Measure 2: Sagittal Spinal Posture | 12 weeks | Primary Outcome Measure 2: Sagittal Spinal Posture Measurement: Lateral Photos (°) Details: In degrees Time Frame:The assessment will be conducted during the first week of treatment and 12 weeks after treatment |
| Primary Outcome Measure 3: Disease-Specific QoL | 12 weeks | Primary Outcome Measure 3: Disease-Specific QoL Measurement: Nuss Questionnaire (1-4) Details: Higher = better Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment |
| Primary Outcome Measure 4: General QoL | 12 weeks | Primary Outcome Measure 4: General QoL Measurement: PedsQL (0-100) Details: Higher = better Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Secondary Outcome Measure 1: Thoracic Cage Mobility | 12 weeks | Secondary Outcome Measure 1: Thoracic Cage Mobility Measurement: Chest Circumference (cm) Details: In cm Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment |
| Secondary Outcome Measure 5: Muscle Endurance (Lateral Bridge) | 12 weeks | Secondary Outcome Measure 5: Muscle Endurance (Lateral Bridge) Measurement: Lateral Bridge (s) Details: Duration Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment |
| Secondary Outcome Measure 2: Spinal Mobility | 12 weeks | Secondary Outcome Measure 2: Spinal Mobility Measurement: Sit-and-Reach (cm) Details: Highest value Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment |
| Secondary Outcome Measure 3: Lumbar Mobility | 12 weeks | Secondary Outcome Measure 3: Lumbar Mobility - Measurement: Modified Schober (cm) Details: Difference in cm Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment |
| Secondary Outcome Measure 4: Muscle Endurance (Sit-Ups) | 12 weeks | Secondary Outcome Measure 4: Muscle Endurance (Sit-Ups) Measurement: Sit-Up (reps/30s) Details: Repetitions Time Frame: The assessment will be conducted during the first week of treatment and 12 weeks after treatment |
Countries
Turkey (Türkiye)
Outcome results
None listed